Bay Area's Versartis Cuts Jobs and Cancels Contracts as it Evaluates a Path Forward Post author:Sam Post published:October 26, 2017 Post category:BioPharma Versartis has retained Cowen to assist in evaluating its strategic options. Source: BioSpace You Might Also Like Massachusetts' Agenus Quietly Discloses Failure of Cancer Vaccine Trial February 21, 2017 Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M November 15, 2017 Bay Area's Guardant Health Just Snagged $360 Million to Create Cancer Blood Tests May 10, 2017
